Addus HomeCare Corporation
ADUS Healthcare Medical Care Facilities
Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024. In the quarter to June 2026, revenue grew 8.01%, EPS grew 24.2%, free cash flow grew 81.7% and total debt fell 63.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
Follow ADUS
Addus HomeCare Corporation (ADUS) EV/Sales
As of 16 October 2026, Addus HomeCare Corporation (ADUS) trades at a EV/Sales of 1.4×. Over the past ten years it has ranged from 0.5× (March 2016) to 2.7× (January 2021); the current reading is higher than 39% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.4× | (28.68%) |
| FY2024 | 2.0× | 33.08% |
| FY2023 | 1.5× | (14.36%) |
| FY2022 | 1.7× | (2.95%) |
| FY2021 | 1.8× | (28.11%) |
| FY2020 | 2.5× | 23.24% |
| FY2019 | 2.0× | 34.47% |
| FY2018 | 1.5× | 57.48% |
| FY2017 | 0.9× | (10.90%) |
| FY2016 | 1.1× | 39.54% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.2× | 4.35% |
| Mar 2026 | 1.2× | (15.98%) |
| Dec 2025 | 1.4× | (14.14%) |
| Sep 2025 | 1.6× | (4.31%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ARDT Ardent Health, Inc. compare | 0.3× |
| ASTH Astrana Health, Inc. compare | 0.6× |
| MD Pediatrix Medical Group, Inc. compare | 1.2× |
| ADUS Addus HomeCare Corporation | 1.4× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 1.6× |
| SGRY Surgery Partners, Inc. compare | 1.6× |
| GRDN Guardian Pharmacy Services, Inc. compare | 1.7× |
| BKD Brookdale Senior Living Inc. compare | 2.1× |
| SNDA Sonida Senior Living, Inc. compare | 6.0× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)